4//SEC Filing
Goldenberg Gary 4
Accession 0001415889-24-019972
CIK 0001660334other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 6:11 PM ET
Size
7.2 KB
Accession
0001415889-24-019972
Insider Transaction Report
Form 4
Goldenberg Gary
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-07-22$7.06/sh−18,421$130,052→ 107,836 total - Sale
Common Stock
2024-07-23$6.98/sh−86$600→ 107,750 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001741938
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 6:11 PM ET
- Size
- 7.2 KB